March 10th, 2004 - Volume 26 - Issue 5
pp: 3-65

The Task for 2015

Simone, Joseph V.

Oncology Times. 26(5):3-4,7, March 10th, 2004.

Defining the task ahead in statistical terms about what is needed to meet the challenge to eliminate suffering and death due to cancer by 2015.


Phase III Trial Assessing 3 Cycles of MVAC in Organ-Confined Bladder Cancer with p53

Stadler, Walter M.; Cote, Richard; Learner, Seth; More

Oncology Times. 26(5):4,7, March 10th, 2004.

An alert about a Phase III trial assessing 3 cycles of MVAC in patients with organ-confined bladder cancer with p53; and a reminder about the important role of radiation oncologists, not just hematologists, in treating victims of radiation terrorism.

Treating Victims of Radiation Terrorism: Important Role of Radiation Oncologists

Whitcopf, Peter

Oncology Times. 26(5):7, March 10th, 2004.

An alert about a Phase III trial assessing 3 cycles of MVAC in patients with organ-confined bladder cancer with p53; and a reminder about the important role of radiation oncologists, not just hematologists, in treating victims of radiation terrorism.




When Will the Children's Oncology Group Reach Maturity? (2nd of 2 Parts): An Interview with COG Chair Gregory H. Reaman, MD

Rosenthal, Eric T.

Oncology Times. 26(5):41-42, March 10th, 2004.

As noted in our 2/25 issue, the merger four years ago of pediatric cancer trials groups into one entity continues to be critiqued, criticized, debated, and defended. In this second part of the article, Dr. Reaman addresses the concerns that were raised.



When the Handwriting's on the Wall


The Closing of NABCO

Rosenthal, Eric T.

Oncology Times. 26(5):24,27, March 10th, 2004.

After 18 years, the pioneering National Alliance of Breast Cancer Organizations is ceasing operations as of June 30. Here's a look at what went into the almost unheard-of decision by an established advocacy group to end its existence outright, without morphing into another identity by changing its mission or perpetuating itself for the sake of self-survival.




1 2 3 4 5